ArticleOncotarget2015

Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.

Melina Schellhorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.